| Faculty | | Superannuated Faculty | | Scientific & Administrative Staff |
|
Name |
Experience |
Professional Interests |
|
Prof. Saranjit Singh, M.Pharm., Ph.D. Professor & Head, Pharmaceutical Analysis ssingh@niper.ac.in |
|
Drug stability testing, Forced decomposition
studies, Development of validated analytical methods, including
stability-indicating assays, Pre-formulation studies, Impurity profiling,
Development of standards for impurities and degradation products. Profile |
|
Prof. U. C. Banerjee, M. Tech, Ph.D., MIE. Professor & Head, Pharmaceutical Technology, In-charge Biotechnology ucbanerjee@niper.ac.in |
|
Biochemical Engineering, Fermentation Technology, Scale up of
Biochemical Processes, Environmental Biotechnology and Downstream
Processing and Biocatalysis |
|
Prof. A. K. Chakraborti, M.Sc., Ph.D. Professor & Head, Medicinal Chemistry akchakraborti@niper.ac.in |
|
Asymmetric synthesis; Development of organometallic reagents/catalysts; Synthesis of Taxanes; Design and synthesis of antiprotozoal, antimitotic and antihypertensive. |
|
Prof. K. P. Ravindranathan Kartha, Ph.D. Professor rkartha@niper.ac.in |
|
Application of Synthetic carbohydrate chemistry to solving problems in cell biology; Synthesis of antitubercular, antimalarial and antidiabetic agents; Isolation, characterization and exploration of biological activity of natural products; Structural/Functional characterization of (and application of chemotaxonomy to) Ayurvedic formulations and development of pharmacopoeial standards for their quality control and evaluation |
|
Prof. Prati Pal Singh |
|
Teaching and Research: Chemotherapy, immunology, bioimmunotherapy and pathogenesis of microbial and parasitic diseases (mainly tuberculosis, malaria, leishmaniasis and amoebiasis); biotechnology; inflammation; mechanisms in host defense; neuroimmunomodulation. |
|
Prof. P. V. Bharatam, M.Sc., Ph.D. Professor pvbharatam@niper.ac.in |
|
Computer aided drug design, Anti-diabetic agent design, NO releasing agents, GSK3, PPARg, AMPK agent design, Studies on Drug Action, Electronic Structure Studies of drugs, Chemoinformatics, Bioinformatics, Pharmacoinformatics, Synthesis of PPARg agents
|
|
Prof. Rahul Jain, M.Sc., Ph.D. |
|
Synthesis and mechanistic study on ultra short neuro and antimicrobial peptides; C-H and C-N activation strategies on natural and unnatural amino acids; synthesis of unnatural amino acids; backbone modification of peptides by C-H and C-N activation strategies; environment friendly peptide synthesis methodologies; new structural classes of antiplasmodial and anti-tuberculosis agents. |
|
Prof. Pramil Tiwari, M. Pharm., Ph.D. Professor & Head, Pharmacy Practice ptiwari@niper.ac.in |
|
Patient safety, pharmaceutical care, geriatric pharmacotherapy, Pharmacovigilance, Pharmaco-economics, antimicrobial usage, clinical pharmacy, Pharmacotherapeutics, Rational use of drugs, Clinical Pharmacy, Good Pharmacy Practice |
|
Prof. Arvind K Bansal, M. Pharm., Ph.D. Professor & Head, Pharmaceutics akbansal@niper.ac.in |
|
Pre-formulation profiling -Physico-chemical characterization -Salt form selection -Permeability studies using Caco-2, everted sac and in situ technique Pharmaceutical material characterization -Polymorphism, pseudo-polymorphism -Molecular understanding of amorphous form -Compaction physics -Understanding material behavior using Dielectric relaxation spectroscopy -Surface characterization of pharmaceuticals Solubility enhancement technologies -‘Stabilization’ amorphous form using solid dispersions -Co-crystals Nanotechnology in drug delivery -Small molecule assisted nano-crystallization -Nano-crystalline solid dispersions -Self nano-emulsifying drug delivery systems Particle engineering -Co-processing to improve physico-technical properties Formulation development of novel and conventional drug delivery systems -Development of lyophilization cycle
De-formulation studies to aid development
of generic products |
|
Prof. Kulbhushan Tikoo, Ph.D. Professor, In-charge, Pharmacology & Toxicology tikoo@niper.ac.in |
|
Epigenetics and
Diseases
|
|
Shyam S. Sharma, M.Pharm., Ph.D., F.I.P.S. Professor sssharma@niper.ac.in |
|
Evaluation of Pharmacological Interventions Targeting Pathophysiological Cascades (Oxidative stress, PARP, ER stress, Inflammation, apoptosis) Involved in Stroke (Cerebral Ischemia), Diabetes, Diabetic Complications (neuropathy, encephalopathy & cardiomyopathy), Cognitive impairment (associated with Parkinson’s disease/Stroke) and Neuropathic Pain. Elucidation of Pharmacological Potential of NCEs in Disease Models for Efficacy Studies Safety Pharmacological Studies (Core, Follow up and Supplemental SPS) of NCEs |
|
Anand Sharma, Ph.D. Associate Professor, In-charge, Pharmaceutical Management anandsharma@niper.ac.in |
|
International Marketing, Strategic Management, Marketing Profile |
|
Sanjay Jachak, M.Pharm, Ph.D. Professor and In-charge, Department of Natural Products sanjayjachak@niper.ac.in |
|
Screening of plant extracts and their isolates (using bioassay-directed fractionation) for COX-2/COX-1 inhibitory activity which may be helpful as the leads for development of safer anti-inflammatory drugs with minimum side effects; design and synthesis of COX-2 inhibitors based on natural products; design and synthesis of microsomal Prostaglandin E2 Synthase (mPGES)-1 inhibitors as novel anti-inflammatory agents; evaluation of synthesized compounds for anti-inflammatory activity in vitro using other molecular targets such as cytokines, TNF-α, IL-1 (IL-1 α and IL-1β) and IL-6; evaluation of most bioactive compounds/lead molecules for anti-inflammatory activity in vivo; bioassay guided isolation and characterization of potential antimycobacterial natural products, discovery of bacterial efflux pump inhibitors from medicinal plants; antioxidant, and anti-diabetic natural products; standardization of herbal drugs and formulations. |
|
Inder Pal Singh, M.Sc., Ph.D. Professor ipsingh@niper.ac.in ipsingh67@yahoo.com |
|
Bioassay-guided isolation and structure elucidation of biologically active compounds from medicinal plants and microorganisms in therapeutic areas of HIV, leishmaniasis and cancer. Design and biomimetic synthesis of bioactive molecules and their analogs for evaluation as anti-HIV, anti-leishmanial, anti-malarial, anti-cancer and antimicrobial agents. Standardization of traditional Ayurvedic/herbal formulations. |
|
Prabha Garg, B.E., M.Tech., Ph.D. Professor prabhagarg@niper.ac.in |
|
Data mining and pattern recognition:
Application of machine learning and statistical methods to
identify the pattern in biological data and chemical data |
|
M. Elizabeth Sobhia, M.Sc., M.Phil., Ph.D Associate Professor mesophia@niper.ac.in |
|
Application of Computer Aided Drug Design methods in lead identification & optimization, in silico studies on ADME/T prediction, design of PTP1B inhibitors, CCR2 agents, PKC-beta2 inhibitors, ALR2 inhibitors, Neuramidase inhibitors, Enoyl reductase inhibitors. |
|
G. B. Jena, M.Sc., M.Phil, Ph.D. Associate Professor gbjena@niper.ac.in ISCA-Young Scientist Award-1999 |
|
Major Research Activities:
DNA damage, autophagy and
carcinogenesis
Chemical intervention in
Pathological Models |
|
Sunil Gupta, M.B.A., Ph.D. Assistant Professor sunilgupta@niper.ac.in |
|
Management & Marketing issues related to Pharmaceutical Industry and HR related issues Profile |
|
Ipsita Roy, Ph.D. Assistant Professor ipsita@niper.ac.in |
|
Downstream processing of proteins; aggregation and stabilization
of misfolded proteins; nonaqueous enzymology; aptamer technology |
|
Anil Kumar Angrish, Ph.D. Associate Professor anil@niper.ac.in |
|
Corporate Finance, Project Appraisal & Finance, Strategic Cost & Financial Management, Management Accounting, and Entrepreneurship Development Profile |
|
Abhay H
Pande, M.Sc., Ph.D. Associate Professor apande@niper.ac.in |
|
Design and Development of Recombinant Protein Pharmaceuticals a) Development of lab-scale technologies for the production of Biosimilars. b) Project 2: Engineering Biobetters. c) Project 3: Development of novel protein pharmaceuticals. |
|
Sankar K. Guchhait, M.Sc., Ph.D. |
|
Anticancer drug discovery: Design and synthesis of heterocyclic compounds as human DNA topoisomerase I and II inhibitors, and their SAR studies Antileishmanial drug discovery: Design and synthesis of heterocyclic compounds as target-specific antileishmanial agents Synthesis of heterocyclic and natural product-based compounds, Direct arene C-H bond functionalization, Multicomponent reaction (MCR) Profile |
|
Chaaya Iyengar Raje, Ph.D. |
|
Host-Pathogen
interaction during Infection |
|
Sanyog Jain, M.Pharm., Ph.D. |
|
Broad Area: Nanotechnology and Drug Delivery Systems Targeted drug delivery using nanocolloidal drug carriers e.g. vesicular carriers (liposomes, niosomes etc.) and particulate carriers (polymeric and lipid nanoparticles). Improving oral bioavailability of poorly water soluble/ poorly permeable drugs using different types of nano formulations. Topical drug delivery using nanoparticles for the topical treatment of psoriasis and other fungal skin infections. Functionalization of carbon nanotubes to improve their dispersibilty in aqueous biological fluid, reduce their toxicity and explore their potential in targeted cancer therapy. Development of antigen loaded nano-carrier systems for oral mucosal immunization. Oral delivery vehicle of insulin for the treatment of diabetes. Non-viral vectors for gene delivery. Radiolabelling and pharmacoscintigraphic evaluation of drug delivery systems. |
|
Sushma Singh, Ph.D. |
|
Leishmania donovani, sirtuins and Leishmania metabolism, Leishmanial MAP kinases, signal transduction in macrophages, drug targets, drug resistance. |
|
Abhay T. Sangamwar, Ph. D. Assistant Professor abhays@niper.ac.in |
|
Broad area: Nano and novel drug delivery systems
|
|
Dipika Bansal Assistant Professor dipikabansal@niper.ac.in |
|
Phase I-Phase IV clinical trials, BABE
studies, Pharmacovigilance, Neuropathic Pain studies, Antimicrobial usage |
|
Manjinder Singh Gill, Ph.D. |
|
Synthetic organic, Process chemistry, Synthesis of compounds with anti-diabetic activity, Process chemistry involving therapeutically important agents, Scale up of new synthetic processes, GMP regulations and Plant Management |
|
Joydev K. Laha, Ph.D. Assistant Professor jlaha@niper.ac.in |
|
Development of new synthetic methodology: Metal-catalyzed decarboxylative intramolecular C-C bond formation, Domino reactions involving C-C and C-N bond formation, Asymmetric organo-catalysis, Green chemistry, Click chemistry, Implementation of laboratory methods to large-scale synthesis Target-driven convergent synthesis: Design and synthesis of novel fluorescent probes and photosensitizers for applications in photodynamic therapy (PDT) and photodynamic anti-bacterial chemotherapy (PACT), ligands for use as nicotinic acetylcholine receptors, small molecule inhibitors of HIV Natural product
synthesis: Agesamides A & B, Mescengricin and other biologically
active compounds. |
|
Superannuated Faculty |
||
|
Name |
Duration |
Profile |
|
Dr. C.L. Kaul Ex. Director |
01-09-1994 to 31-08-2004 |
|
|
Prof. H.P.S. Chawla Ex. Dean |
05-04-2000 to 13-04-2002 |
|
|
Prof. K.K. Bhutani Ex. Officiating Director |
31-12-2009 to 31-12-2016 |
|
Page Last Updated / Reviewed on: 14-February-2017
|
||Archives| About this Site| Terms of Use | Content Review Policy | Hyperlink Policy |Internet Access Policy| Sitemap| Help | Contact Us | |
|
|Copyright©2011 NIPER S.A.S. Nagar |Feedback: Webmaster | Best View: 1024 X 768 | Disclaimer | |